Seeking Alpha

Sangamo BioSciences (SGMO -4.5%) takes a bit of a hit this morning, despite the presentation of...

Sangamo BioSciences (SGMO -4.5%) takes a bit of a hit this morning, despite the presentation of new data demonstrating the successful application of its In Vivo Protein Replacement Platform in a mouse model. The company, in partnership with Shire (SHPG +1.8%), is developing ZFP Therapeutics for both hemophilia A and B using this approach. The data was presented late last week at the 16th Annual Meeting of the American Society of Gene and Cell Therapy in Salt Lake City.
Comments (3)
  • jsmith9248
    , contributor
    Comment (1) | Send Message
     
    SGMO failed to turn sandstone into gold or demonstrate 100%
    HIV eradication from blood and reservoirs.
    Hot and scared money left.
    I counsel patience. With all that SGMO has learned to date,
    The next trials will show even better results against
    more targeted heterozygous groups of patients.
    STOCKGAMBLER1
    20 May 2013, 01:36 PM Reply Like
  • Giovanni di Maggio
    , contributor
    Comments (48) | Send Message
     
    I agree with jsmith9248
    20 May 2013, 03:46 PM Reply Like
  • rcostos
    , contributor
    Comments (4) | Send Message
     
    Way too many other applications for their technology not to have a piece of this company tucked away in the top drawer. Big companies way smarter then we are are investing large sums annually to have a piece of the various discoveries coming out of their pipeline. Very smart way of financing, producing much lower risk for the investor and long staying power for Sangamo to complete their promising projects. Don't let the short term noise shale you out of this stock!
    21 May 2013, 09:25 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs